Evidence map›Paper›PMID 21829372›Full record

ArticlePLoS genetics2011

Pervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutations.

Rui F Silva, Sílvia C M Mendonça, Luís M Carvalho, Ana M Reis, Isabel Gordo, Sandra Trindade, Francisco Dionisio

Abstract read
In one paragraph

Article in PLoS genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A plasmid with theMicrobiology (Reading, England) · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Intrahost evolution of the gut microbiota.Nature reviews. Microbiology · 2023
    Review
  14. Review
  15. Review
  16. Article
  17. Translational demand is not a major source of plasmid-associated fitness costs.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022
    Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rui F SilvaCentro de Biologia Ambiental, Faculdade de Ciências da Universidade de Lisboa, Lisboa, Portugal.
Sílvia C M Mendonça
Luís M Carvalho
Ana M Reis
Isabel Gordo
Sandra Trindade
Francisco Dionisio

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant bacteria arise mostly by the accumulation of plasmids and chromosomal mutations. Typically, these resistant determinants are costly to the bacterial cell. Yet, recently, it has been found that, in Escherichia coli bacterial cells, a mutation conferring resistance to an antibiotic can be advantageous to the bacterial cell if another antibiotic-resistance mutation is already present, a phenomenon called sign epistasis. Here we study the interaction between antibiotic-resistance chromosomal mutations and conjugative (i.e., self-transmissible) plasmids and find many cases of sign epistasis (40%)--including one of reciprocal sign epistasis where the strain carrying both resistance determinants is fitter than the two strains carrying only one of the determinants. This implies that the acquisition of an additional resistance plasmid or of a resistance mutation often increases the fitness of a bacterial strain already resistant to antibiotics. We further show that there is an overall antagonistic interaction between mutations and plasmids (52%). These results further complicate expectations of resistance reversal by interdiction of antibiotic use.

Indexed as

Conjugation, GeneticEpistasis, GeneticAnti-Bacterial AgentsChromosomes, BacterialDrug Resistance, BacterialEscherichia coliEscherichia coli ProteinsMutationPlasmidsAnti-Bacterial AgentsEscherichia coli Proteins

Identifiers

PMID21829372
PMCPMC3145620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.